Exhibit 10.1


FORM
OF 


EXCLUSIVE
LICENSE AGREEMENT


THIS EXCLUSIVE LICENSE
AGREEMENT (“Agreement”) is made effective as of the date last signed below (“Effective Date”) by and between Eco
Innovation Group, Inc., a Nevada corporation with a principal place of business and offices at 16525 Sherman Way, Suite C-1, Van Nuys,
CA 91406 (“LICENSEE”), and Lance E. Nist (“LICENSOR”). LICENSEE and LICENSOR are each referred to individually
as “Party” and collectively as “Parties.” The Parties hereby agree as follows:


ARTICLE 1: INTRODUCTION


1.1 LICENSOR
has developed the energy efficiency technologies listed in Appendix A, attached to and hereby incorporated as an integral part
of this Agreement, related to the inventions of LICENSOR (hereinafter the “Technologies”) as defined in Article 2.11 below.


		1.2	LICENSEE wishes to obtain the right to develop and to commercialize the inventions disclosed in the Technologies,
which are owned by LICENSOR.



1.3 LICENSOR
has the exclusive right to license LICENSOR’s right, title and interest in and to the Technologies and the oversight of the patenting
of the Technologies.


		1.4	The Parties agree to the terms and conditions herein below in order to develop the Technologies for commercial
purposes and utilize them in the public interest.



ARTICLE 2: DEFINITIONS


2.1 “Affiliate”
shall mean (1) any corporation or other noncorporate entity owning directly, or indirectly controlling, at least fifty percent (50%) of
the stock normally entitled to vote for election of directors of LICENSEE; (2) any corporation owned or controlled by LICENSEE through
ownership of at least fifty percent (50%) of the stock entitled to elect directors or any other entity actually controlled by LICENSEE,
(3) any corporate or noncorporate entity under common control with LICENSEE.


		2.2	“Applications” shall mean any patent applications, domestic or foreign, based on the Technologies
listed in Appendix A.



 


2.3 “Covered”
shall mean, with respect to a Product and a country, that, in the absence of ownership of or a license granted under a Valid Claim in
such country, the manufacture, use, offer for sale, sale or importation of such Product would infringe such Valid Claim (or, in the case
of a Valid Claim in an Application, would reasonably likely infringe such Valid Claim if it were to issue in a Patent).


2.4        “Dollars”
or “$” shall mean United States Dollars.


2.5 “Exclusive”
shall mean that during the term of this Agreement LICENSOR will not grant commercial rights to the Technologies to any other party.


2.6        “Licensed
Territory” shall mean the world.


 






    	  





    	 



    

 


2.7 “License
Year” shall mean each twelve-month period beginning on January 1 and ending on December 31. However, the first License Year (alternatively,
License Year 1) shall commence on the Effective Date and end on December 31 of the same calendar year.


2.8 “Net
Sales” shall mean the gross amount invoiced for sales, leases and other dispositions of Products by LICENSEE, and Sublicensees,
to an independent third party on sale or use of Products where Products are either made, used, sold, imported, exported, or otherwise
commercialized less (i) all trade, quantity, and cash discounts actually allowed on Products, (ii) all credits and allowances actually
granted on Products on account of rejection, returns, billing errors, and retroactive price reductions, (iii) duties actually paid on
Products, and (iv) excise, sale and use taxes, and equivalent taxes actually paid on Products.


2.9 “Patents”
shall mean (a) all patents issuing from any patent application for the Technologies, (b) all reissues, reexaminations and extensions of
any patent described in (a) above, (c) any patent sharing a common claim of priority with any of the patents described in (a) and (b)
above, and (d) any patent application for the Technologies, pending or otherwise.


2.10 “Products”
shall mean any product or service that incorporates, utilizes or is otherwise described and claimed by one or more Patents or applications
for Patents, Valid Claims, or that are made by a process that utilizes or incorporates the Technologies, and any services that incorporate
or utilize the Technologies or are otherwise described and claimed in Patents, or applications for Patents.


2.11 “Technologies”
shall mean (a) the technologies listed in Appendix A, (b) any patent applications based thereon, domestic or foreign, (c) all divisionals
and continuations of any of the patent applications described in (b) above, and (c) any patent application sharing a common claim of priority
with any of the patent applications described in (b) above.


2.12 “Valid
Claim” shall mean a claim of (i) an issued Patent which has not been declared invalid in a court of appropriate jurisdiction, or
(ii) a pending patent Application which is being diligently prosecuted by or on behalf of LICENSOR.


ARTICLE 3: APPLICATIONS AND PATENTS


3.1 LICENSOR
represents that LICENSOR holds title to all Technologies, Patents and/or Applications for Patents.


3.2 LICENSOR
shall, after completion of an operable prototype that provides proof of concept for at least one Product utilizing one of the Technologies,
use reasonable efforts to file and prosecute Patents, Applications and to maintain Patents. At any time during the term of this Agreement,
LICENSEE may elect in writing to be released from its license in any of the Patents or their applications, in which event LICENSEE shall
thereafter have no obligation to reimburse LICENSOR for any future expenses relating to such Patents or Patent applications, and LICENSOR
shall have the option at its sole discretion and expense to file, prosecute, maintain and license to a third party such Patents.






    	  





    	 



    

 


3.3 LICENSEE
shall pay for all costs for preparation, filing, prosecution and maintenance of Applications and Patents except for those Patents for
which it has waived its rights, in writing. Such payments shall include those incurred prior to Effective Date. LICENSOR shall create
purchase orders for all necessary equipment. Reimbursements may be made for out of pocket expenses by specifying the date the expense
was incurred, the purpose of the expense to which the expense relates.


3.4 LICENSEE
shall have final authority over selection of patent attorneys and all decisions concerning filing and prosecution of Applications and
maintenance of Patents. However, LICENSEE shall keep LICENSOR reasonably informed of its filing, prosecution and maintenance activities
and shall give LICENSOR the opportunity to comment on major decisions concerning such activities.


3.5 Neither
Party shall at any time, directly or indirectly, oppose the grant of, nor dispute the validity or enforceability of, nor cooperate in
any suit, claim, counterclaim or defense against any patent or claim included in the Patents.


ARTICLE 4: LICENSE GRANT AND COMMERCIAL
EFFORTS


4.1 Subject
to the terms and conditions of this Agreement, LICENSOR hereby grants and LICENSEE hereby accepts an exclusive right to make, use, sell,
lease, import, export or otherwise dispose of Products under all (including LICENSOR’s) rights, title and interest in and to the
Applications and Patents in the Licensed Territory for the term of this Agreement as specified in Section 7.1.


4.2 The
right of LICENSEE to make Products includes the right to have Products made by contract with third parties within the Licensed Territory.
Such contractual arrangements with third parties shall be subject to and conditioned upon appropriate supervision and quality assurance
and control of the third party by LICENSEE and the third party shall be bound in writing to respect all rights of LICENSOR and to supply
all production of Products exclusively to LICENSEE.


4.3 LICENSOR
retains an irrevocable and nonexclusive right to practice for its own research purposes, the inventions claimed in Applications and Patents.


4.4 Nothing
in this Agreement shall be construed to give LICENSEE rights in any technologies currently owned or developed in the future by LICENSOR
other than those explicitly specified in this Agreement. Nothing in this Agreement shall be construed to give LICENSOR rights in technologies
currently owned or developed in the future by LICENSEE other than those explicitly specified in this Agreement.


4.5 The
rights granted by this Agreement are to LICENSEE alone and not to any third parties or to any subsidiary or Affiliate of LICENSEE. However,
with prior written approval of LICENSOR (such approval not to be unreasonably withheld), LICENSEE may transfer this Agreement by way of
sale of LICENSEE, through sale of assets and/or sale of stock, provided that such sale is not primarily for the benefit of creditors.
If LICENSEE fails to obtain the prior written approval from LICENSOR for such transfer, LICENSOR shall have the right to terminate this
Agreement and the right to require that the transfer of this Agreement be voided.


4.6 LICENSEE
shall use its Best Efforts, consistent with sound and reasonable business practices and judgment, to affect commercialization of Products
as soon as practicable and to maximize sales thereof.


4.7 LICENSEE
shall alone have the obligation to ensure that Products it makes, uses, sells, leases, imports, exports or otherwise disposes of are not
defective, that Products satisfy all applicable government regulations and that export of Products satisfies government export requirements.






    	  





    	 



    

 


4.8 In order
to further the cooperation between LICENSOR and LICENSEE in the interest of the joint commercial development of the Technologies and the
filing of the Applications and the Patents, LICENSEE shall appoint, and LICENSOR shall designate, a LICENSOR representative to a position
on LICENSEE’s board of advisors pursuant to a separate agreement between the Parties. LICENSEE shall have the right to publish and
distribute the name, likeness and quotes attributable to such advisor appointee in relevant press releases, copies of which will be provided
to LICENSOR.


 


ARTICLE 5: PAYMENTS, ROYALTIES,
REPORTS AND RECORDS


5.1


As consideration
for entering into this Agreement, LICENSEE shall pay the cost to build a prototype in an amount up to five thousand dollars ($5,000.00)
and shall grant LICENSOR a restricted stock award for five million (5,000,000) shares of LICENSEE’s common stock, subject to applicable
laws and regulations, and subject to a vesting schedule pursuant to the stock award grant entered into between the Parties. LICENSOR represents
that LICENSOR is a non-U.S. resident for U.S. income tax purposes, acknowledges that LICENSOR may recognize U.S. source compensation income
based on the number of work days spent in U.S. pursuant to this Agreement, and that double taxation may occur depending on the laws of
LICENSOR’s country of residence, and further acknowledges that Pool Cooled shall comply with any applicable U.S. legal requirements
for withholding with regards to the payment of compensation and royalties under this Agreement.


		5.2	The Parties anticipate that, after completion of an operable prototype that provides proof of concept for
at least one Product utilizing one of the Technologies, LICENSEE will form a wholly owned subsidiary for the purpose of commercializing
the Products and the Technologies, to be named “Pool Cooled Technologies, Inc.” (“Pool Cooled Technologies”).



5.3 For
the rights granted hereunder, LICENSEE shall pay or cause to be paid to LICENSOR a royalty on Net Cost of Goods of Products, on a Product-by-Product
and country-by-country basis, where the manufacture, use, sale, offer for sale or importation of such Product by LICENSEE in such country
is Covered by a Valid Claim, as per the following table:


	Product 	Royalty
	All Products	10%



  


5.4 LICENSEE
shall keep and maintain any and all records necessary to certify compliance of LICENSEE with the terms of this agreement, including but
not limited to accounting general ledgers, Sublicense and distributor agreements, price lists, catalogs, and marketing materials, audited
financial statements, income tax returns, sales tax returns, inventory records, and shipping documents of Products. Such records shall
be open to inspection at reasonable times by a certified public accountant chosen by LICENSOR and acceptable to LICENSEE, which shall
not unreasonably withhold such acceptance. Such inspection shall be made at LICENSOR’s expense. However, if the results of any audit
reveal additional royalties owed to LICENSOR that differ by more the 5% (Five percent) from those royalties already paid, LICENSEE shall
also reimburse LICENSOR for the costs of the audit. LICENSOR agrees to hold such records confidential, except as may be necessary to maintain
an action against LICENSEE for breach of this Agreement. The records required by this paragraph shall be maintained and available for
inspection for a period of 5 years following the calendar quarter to which they pertain. This paragraph shall survive termination of this
Agreement.






    	  





    	 



    

 


5.5 LICENSEE
agrees to make a written report to LICENSOR within 30 days after the expiration of this Agreement pursuant to Section 7.1. LICENSEE shall
continue to make reports pursuant to the provisions of this Section 5.6 concerning royalties payable in accordance with Section 5.3 in
connection with the sale of Products after expiration of the license, until such time as all such Products produced under the license
have been sold or destroyed. Concurrent with the submittal of each post-termination report, LICENSEE shall pay LICENSOR all applicable
royalties.


ARTICLE 6: INFRINGEMENT


		6.1	In the event that either Party determines that a third party is making, using or selling a product that may
infringe Patents, it will promptly notify the other Party in writing. LICENSEE may, in LICENSEE’s sole discretion, elect to bring
suit against such alleged infringer. All recoveries in such suit shall belong to LICENSEE except that LICENSOR shall have the right to
elect to pay up to fifty percent (50%) of the litigation costs and receive a percentage of any recovery equal to the percentage of litigation
costs paid. LICENSOR must make such election within 60 days after its receipt of notice that LICENSEE has elected to bring suit. LICENSOR
shall also have the right to choose to be represented by separate counsel in any such suit at its own expense. Such expense for separate
counsel shall not be considered as part of “litigation costs” for purposes of determining LICENSOR’s share of any recovery
in accordance with the sentence above. If LICENSEE elects not to bring a suit against the alleged infringer, it shall promptly notify
LICENSOR of that fact and LICENSOR shall have the right to commence such actions at its own cost and expense, in which case any recoveries
shall belong to LICENSOR. In such suits by LICENSOR, LICENSEE shall have rights of participation and recovery that are the same as LICENSOR’s
rights as provided above when LICENSEE elects to sue.



		6.2	Regardless of which Party controls a suit brought against an infringer, each Party shall participate in
any settlement discussions and each will be a signatory to any settlement agreement.



ARTICLE 7: TERM AND TERMINATION


7.1 This
Agreement shall commence on the Effective Date, and shall continue as an Exclusive license until the last of all Patents has either expired
or been invalidated in an unappealed decision by a court having jurisdiction and no Applications remain pending, and provided this Agreement
is not earlier terminated as provided for herein.


7.2        LICENSOR
may terminate this Agreement if LICENSEE:


		(i)	is in default in payment of license fees, royalties or cost reimbursements or in providing



 


reports;


		(ii)	is in material breach of any provision of this Agreement; or



 






    	  





    	 



    

 


		(iii)	intentionally provides any false report;



and LICENSEE fails
to remedy any such default, breach, or false report within 60 days after written


notice thereof
by LICENSOR. LICENSEE’s right to terminate this Agreement on a Product-by Product basis is as set forth in Paragraph 7.4.


		7.3	LICENSOR may terminate this Agreement upon thirty (30) days written notice by LICENSOR if LICENSEE fails
to obtain prior written LICENSOR approval for the transfer of this Agreement upon the sale of LICENSEE in accordance with Section 4.6,
provided that such notice is given within sixty (60) days after such transfer.



		7.4	LICENSEE may terminate the license granted hereunder, in its entirety or on a Patent-by- Patent basis,
a Product-by-Product, and/or a country-by-country basis if LICENSEE has a reasonable basis for doing so, at any time upon sixty (60) days’
notice to LICENSOR. Such notice must be in writing and obligations under this Agreement shall continue to accrue during the sixty (60)
day notice period, including the obligation to make any payments under this Agreement.



		7.5	Upon termination of this Agreement for any reason, including the end of term as specified above, all rights
and obligations under this Agreement shall terminate, except those that have accrued prior to termination and except as specified in this
Agreement.



ARTICLE 8: PUBLICATION AND CONFIDENTIALITY


8.1        LICENSOR
shall retain the right to publish information described in Applications and Patents.


8.2 Each
Party agrees to keep any information identified as confidential by the disclosing Party confidential using methods at least as stringent
as each Party uses to protect its own confidential information, except as may be necessary for LICENSEE to meet its public company reporting
requirements pursuant to applicable laws or to audit LICENSEE as specified under Section 5.6. “Confidential Information” shall
include the progress report required under Section 4.8 and any other information marked confidential or accompanied by correspondence
indicating such information is confidential exchanged between the Parties hereunder. The confidentiality and use obligations set forth
above apply to all or any part of the Confidential Information disclosed hereunder except to the extent that:


		(a)	LICENSEE discloses the Confidential Information pursuant to its reporting requirements under
the Securities Act or the Exchange Act;






		(b)	LICENSEE or LICENSOR can show by written record that it possessed the information prior to
its receipt from the other Party;






		(c)	The information was already available to the public or became so through no fault of the LICENSEE or
LICENSOR;



 


		(d)	The information is subsequently disclosed to LICENSEE or LICENSOR by a third party that has the right
to disclose it free of any obligations of confidentiality; or



 






    	  





    	 



    




		(e)	Two (2) years have elapsed from the expiration of this Agreement.



ARTICLE 9: ARBITRATION AND JUDICIAL
REMEDIES


9.1 If a
controversy arises under or related to this Agreement, and any disputed claim by either Party against the other Party under this Agreement,
excluding any dispute relating to patent validity or infringement arising under this Agreement, the Parties shall endeavor to resolve
such controversy or dispute by mutual, good faith conciliation and, failing that, may mutually agree to settle the controversy or dispute
by mediation in accordance with the WIPO Mediation Rule. The place of mediation shall be Los Angeles, California. In the event a dispute
is not resolved by mediation, each Party agrees, relevant to any claim, to waive their rights to litigate in a court of law or equity,
or to a jury trial, but rather agree their exclusive remedy is binding arbitration to be held in Los Angeles, County, California. Each
Party shall bear their own costs of arbitration, but the prevailing Party shall be entitled to reimbursement of all costs, fees, and expenses
(i.e. all reasonable preand post-award expenses of the arbitration fees for representation, travel, and out-of-pocket expenses).


ARTICLE 10: INDEMNIFICATION


10.1 LICENSEE
agrees to indemnify, defend and hold harmless LICENSOR and his respective officers, employees, and agents against any and all claims for
death, illness, personal injury, property damage, damages, expenses, losses and improper business practices arising out of (i) the manufacture,
use, sale, or other disposition of Patents or Products by LICENSEE, Sublicensee, or their customers, (ii) a third party’s use of
a Product purchased, leased, or otherwise acquired from LICENSEE or Sublicensee, or (iii) a third party’s manufacture or provision
of a Product at the request of LICENSEE or Sublicensee.


10.2 LICENSOR
shall not be liable for any indirect, special, consequential, or other damages whatsoever, whether grounded in tort (including negligence),
strict liability, contract or otherwise. LICENSOR shall not have any responsibilities or liabilities whatsoever with respect to Products.


10.3 LICENSEE
and Sublicensee shall at all times comply, through insurance or self-insurance, with all statutory workers’ compensation and employers’
liability requirements covering any and all employees with respect to activities performed under this Agreement.


10.4 The provisions
of this Article 10 shall survive termination of this Agreement.


ARTICLE 11: WARRANTIES AND LIMITATIONS


11.1 Each
of LICENSOR and LICENSEE represent and warrant that it has the right to enter into this Agreement. LICENSOR warrants that he has the right
to convey to LICENSEE the rights granted under this Agreement.


11.2 LICENSOR
represents that to the best of its knowledge the inventorship and ownership of the Technologies and Patents is as set forth in this Agreement.


11.3 LICENSOR makes
no representation or warranty that Applications will result in issued Patents.


11.4 LICENSOR makes
no representations or warranties concerning the validity or scope of Patents.






    	  





    	 



    

 


11.5 LICENSOR
does not warrant that Products made, used, sold, leased, imported, exported or otherwise disposed of under the license of this Agreement
is or will be free from infringement of patents of third parties.


11.6 Nothing
herein shall be construed as granting by implication, estoppel, or otherwise any licenses or rights under patents or other rights of LICENSOR
or other persons other than Patents, regardless of whether such patents or other rights are dominant or subordinate to any Patents.


11.7 LICENSOR
is under no obligation to furnish any technology or information other than that described and claimed in Applications and Patents.


11.8 Nothing
herein shall be construed to grant LICENSEE rights under any applications or patents other than Applications and Patents.


11.9 LICENSOR
does not make any representations, extend any warranties of any kind, express or implied, or assume any responsibility whatever concerning
the manufacture, use, or sale, lease or other disposition by LICENSEE or its vendees or transferees of Products.


11.10 Except
as expressly set forth in this Agreement, NEITHER PARTY MAKES NO REPRESENTATIONS AND EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS
OR IMPLIED. THERE ARE NO EXPRESS OR IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR THAT THE USE OF PRODUCTS
WILL NOT INFRINGE ANY PATENT, COPYRIGHT, TRADEMARK, OR OTHER RIGHTS OR ANY OTHER EXPRESS OR IMPLIED WARRANTIES.


ARTICLE 12: MARKING


12.1 Prior
to the issuance of patents on the Applications, LICENSEE shall mark Products (or their containers or labels) made, sold, leased, imported,
exported or otherwise disposed of by it under the license granted in this Agreement with the words “Patent Pending”, and following
the issuance of one or more Patents, with each Patent’s Number.


ARTICLE 13: MISCELLANEOUS PROVISIONS


13.1 Terms
in this Agreement which appear capitalized, other than the names of the Parties and article headings, have the meanings given in Article
2 and retain those meanings whether used in the singular or plural.


13.2 This
Agreement shall be binding upon and be to the benefit of the Parties and their heirs, successors and permitted assigns. However, neither
Party shall assign this Agreement, in whole or in part, without the written consent of the other Party, which consent shall not be unreasonably
withheld or delayed.


 






    	  





    	 



    

 


13.3 All
issues and questions concerning the construction, validity and interpretation of this Agreement shall be governed by, and construed in
accordance with, the laws of the State of California without giving effect to any choice of law or conflict of law rules or provisions
(whether of the State of California or any other jurisdiction) that would cause the application of the laws of any jurisdiction other
than the State of California. In furtherance of the foregoing, the internal law of the State of California shall control the interpretation
and construction of this Agreement, even though under that jurisdiction’s choice of law or conflict of law analysis, the substantive
law of such other jurisdiction would ordinarily apply. The Parties hereby irrevocably and unconditionally submit to the exclusive jurisdiction
of any State court sitting in Los Angeles County, State of California or Federal court sitting in Los Angeles, California over any suit,
action or proceeding arising out of or relating to this Agreement and agree that no such suit, action or proceeding shall be brought in
any other court, forum or jurisdiction. The Parties hereby irrevocably and unconditionally waive any objection to the laying of venue
of any such suit, action or proceeding brought in any such court and any claim that any such suit, action or proceeding brought in any
such court has been brought in an inconvenient forum. LICENSOR and LICENSOR acknowledge that LICENSEE is subject to the reporting requirements
of the Securities Act and the Exchange Act, and agree to cooperate with LICENSEE and facilitate the business of this Agreement pursuant
to those reporting and compliance matters.


13.4 All
notices required or permitted hereunder shall be in writing and be served on the Parties at the addresses set forth below. Any such notices
shall be either (a) sent by a nationally recognized overnight courier, in which case notice shall be deemed delivered when delivery is
made according to the records of such courier, (b) sent by email, in which case notice shall be deemed delivered upon receipt of confirmation
of transmission of such electronic mail notice, or (c) sent by personal delivery, in which case notice shall be deemed delivered upon
receipt. Any notice by facsimile or personal delivery and delivered after 5:00 p.m., Pacific Standard Time, shall be deemed received on
the next Business Day. A Party’s address may be changed by written notice to the other Party; provided, however, that no
notice of a change of address shall be affected until actual receipt of such notice.


 


In the case of LICENSOR:


Lance
E. Nist


2824 S. Willis St.


Santa Ana, CA
92705


Tel.: 949-250-1797


Email: panteraefi@gmail.com


 


In the case of LICENSEE:


Eco Innovation
Group, Inc.


Attn: Julia Otey-Raudes


16525 Sherman
Way, Suite C-1


Van Nuys, CA
91406


Tel.: 818-310-1806


Email: julia.otey@ecoig.com


 


With a copy to:


 


Robert Hymers


Pinnacle Tax
Services


520 S Grand Ave
#320


Los Angeles,
CA 90071


Tel. : 310-926-3980


Email : roberthymers@yahoo.com


 






    	  





    	 



    

 


13.5 No
term or provision of this Agreement shall be waived and no breach excused unless such waiver or consent shall be in writing and signed
by the Party claimed to have waived or consented. No waiver of a breach shall be deemed to be a waiver of a different or subsequent breach.


13.6 This
Agreement may not be modified, changed or terminated orally. No change, modification, addition or amendment shall be valid unless in writing
and signed by the Parties.


13.7 In
the event any provision of this Agreement is determined to be invalid or unenforceable, the remaining provisions shall remain in full
force and effect.


13.8 This
Agreement constitutes and contains the entire agreement of the Parties respecting its subject matter and supersedes any and all prior
negotiations, correspondence, understandings and agreements, whether written or oral, between the Parties respecting its subject matter.


13.9 This
Agreement may be executed in counterparts with the same force and effect as if executed in one complete document by both Parties as listed
below. Any photocopy or facsimile copy of this fully executed Agreement shall have the same legal force and effect as any copy bearing
original signatures. Signatures transmitted by facsimile shall be deemed valid as original signatures.


13.10 For
clarity, in furtherance of fulfilling its obligations and exercising its rights under this Agreement, LICENSEE may employ third parties,
including but not limited to contract manufacturers, contract research organizations and contract sales organizations, to carry out activities
on LICENSEE’s behalf, without any obligation to obtain consent from LICENSOR therefor.


IN WITNESS of this Agreement,
LICENSOR and LICENSEE have caused this Agreement to be executed by their duly authorized officers on the dates indicated.


LANCE E. NIST
 ECO INNOVATION GROUP, INC.


	
     

    By:
	
     

    /s/ Lance E. Nist
	      By:	
     

    /s/ Julia Otey-Raudes

	Name:	  Lance E. Nist	Name:	Julia Otey-Raudes
	Title:	  Individually	Title:	Chief Executive Officer
	Date:	  June 8, 2021	Date:	June 8, 2021


 





 




    	  





    	 



    


 


APPENDIX A


POOL COOLED
TECHNOLOGIES


 


Additional Technologies
developed and designed by LICENSOR may be added to this Agreement by attaching and dating an Addendum to this Appendix A.


 


 


		1)	Pool Cooled equipment



 


 


		2)	ECOX PoolCooledTM 



 


 


		3)